Carbidopa And Levodopa
Product Images NDC 42291-466

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 42291-466). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

465 (465 01 10mg 100mg 100)

Packaging label for Carbidopa and levodopa Tablets, USP by AvKARE, showing a strength of 10 mg/100 mg. The label indicates the container holds 100 tablets, prescription only. Additional text includes dosage form, drug composition per tablet, and storage instructions.*

FDA Label Image

466 (466 01 25mg 100mg 100)

Packaging label for Carbidopa and Levodopa Tablets, USP, 25 mg/100 mg strength by AvKARE. The label indicates a package of 100 tablets, prescription only (Rx only). It includes an NDC number 42291-466-01 and storage instructions to keep the product out of reach of children and protect from light. Manufacturer details include AvKARE Inc., Pulaski, TN 38478, USA.*

FDA Label Image

467 (467 01 25mg 250mg 100)

Label for Carbidopa and Levodopa Tablets, USP by AvKARE, with each tablet containing 25 mg Carbidopa and 250 mg Levodopa. The label indicates a quantity of 100 tablets, prescription only. Includes NDC 42291-467-01 and manufacturer information for AvKARE in Pulaski, TN.*

FDA Label Image

67944b5f-figure-01 (Image 1)

Chemical structure diagram of the active ingredient in Carbidopa and levodopa, showing the molecular arrangement and bonds of the compound including hydroxyl groups, methyl group, carboxyl group, hydrazine moiety, and a water molecule (hydrate).*

FDA Label Image

67944b5f-figure-02 (Image 2)

Chemical structure of the active ingredient shown, depicting a molecule with a benzene ring substituted with hydroxyl groups and an amino acid side chain characteristic of levodopa or carbidopa.*

FDA Label Image

67944b5f-figure-03 (Image 3)

The image shows the front of a rectangular cardboard box for Carbidopa and levodopa by AvKARE. The box displays the proprietary name prominently and includes visible text elements and graphics indicative of pharmaceutical packaging but no detailed strength, dosage form, or count information is fully visible.*

FDA Label Image

67944b5f-figure-04 (Image 4)

Carbidopa and levodopa tablet packaging label from AvKARE. The label includes barcodes and various standard identifiers. The packaging is white with black text, showing no specific strength, dosage form, or package size information visible in the image.*

FDA Label Image

67944b5f-figure-05 (Image 5)

Carbidopa and levodopa tablet bottle label by AvKARE. The label shows drug name, dosage form as tablets, and quantity (100 tablets). Key information such as strength and NDC code is present but not fully legible in the image. The label includes usage instructions, barcodes, and regulatory text on a white background with blue and red accents.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.